articleNature MedicineAug 19, 2007Closed access

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Institut Gustave Roussy · Université Paris-Sud · +12 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,957
total citations
FWCI
40.53
Percentile
100%
References
49
Citations per year

Authors

28

Topics & keywords

Keywords
  • Immunogenic cell death
  • Immunoadjuvant
  • Radiation therapy
  • Immune system
  • Cancer research
  • Toll-like receptor
  • HMGB1
  • Acquired immune system
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.